BridgeBio Oncology Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2025 | $-113.9M | $-114.5M | $606.0K | $5.9M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2025 | $-113.9M | $-114.5M | $606.0K | $5.9M |